scispace - formally typeset
J

John Q. Trojanowski

Researcher at University of Pennsylvania

Publications -  1538
Citations -  245534

John Q. Trojanowski is an academic researcher from University of Pennsylvania. The author has contributed to research in topics: Dementia & Alzheimer's disease. The author has an hindex of 226, co-authored 1467 publications receiving 213948 citations. Previous affiliations of John Q. Trojanowski include Vanderbilt University & University of California, San Francisco.

Papers
More filters
Journal ArticleDOI

Multimodal predictors for Alzheimer disease in nonfluent primary progressive aphasia

TL;DR: Neither PPA phenotyping nor imaging alone is a reliable predictor of pathology, but multimodal predictors, such as combining neuropsychological testing with MRI analysis, can improve noninvasive prediction of underlying pathology in nonfluent forms of PPA.
Journal ArticleDOI

Qualification of a surrogate matrix-based absolute quantification method for amyloid-β₄₂ in human cerebrospinal fluid using 2D UPLC-tandem mass spectrometry.

TL;DR: The newly established surrogate matrix for 2D-UPLC-MS-MS measurement of Aβ42 provides selective, reproducible, and accurate results and supports consideration as a candidate reference method.
Journal ArticleDOI

Molecular milestones that signal axonal maturation and the commitment of human spinal cord precursor cells to the neuronal or glial phenotype in development

TL;DR: Immunohistochemical studies conducted on 22 human fetal spinal cords with gestational ages that ranged from 6 to 40 weeks by using monoclonal antibodies to several classes of neuron or glial specific polypeptides addressed the problem of lack of information on the human counterparts of the relatively small subset of well‐characterized, developmental regulated neuron and glialspecific genes of the mammalian CNS.
Journal ArticleDOI

Nosology of Parkinson’s Disease: Looking for the Way Out of a Quackmire

TL;DR: It is timely to define a nosology for these diseases that is based on their genetic and molecular underpinnings, as proposed here.
Journal ArticleDOI

A mutation affecting the sodium/proton exchanger, SLC9A6, causes mental retardation with tau deposition

TL;DR: A family with severe mental retardation characterized by the virtual absence of speech, autism spectrum disorder, epilepsy, late-onset ataxia, weakness and dystonia is studied, revealing a probable interaction between sodium/proton exchangers and cytoskeletal elements involved in vesicular transport and raising the possibility that abnormalities of vesicle targeting may play an important role in more common disorders.